Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of isavuconazole intermediate

A technology for isavuconazole and intermediates, which is applied in the field of preparation of isavuconazole intermediates, and can solve the problems of unsuitable for large-scale industrial production, complex preparation process, and high cost of raw materials

Inactive Publication Date: 2016-07-06
KBP BIOSCIENCES CO LTD
View PDF3 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The existing preparation process of isavuconazole intermediate (formula 1) is complex, the cost of raw materials is high, and it is not suitable for large-scale industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of isavuconazole intermediate
  • Preparation method of isavuconazole intermediate
  • Preparation method of isavuconazole intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0065] Example 4-(2-((2R,3R)-3-(2,5-difluorophenyl)-3-hydroxyl--4-(1H-1,2,4-triazol-1-yl ) butane -2-yl) thiazol-4-yl) preparation of benzonitrile (formula 1)

[0066]

[0067] (1) Preparation of 2,5-difluorobenzoic acid methyl ester (formula 3)

[0068] 2,5-difluorobenzoic acid (31.6g, 0.2mol) and thionyl chloride (35.7g, 0.3mol) were dissolved in 500mL of methanol, and the reaction was heated under reflux until the reaction was completed. After cooling, ice water was added, extracted with ethyl acetate, and the organic phase was dried and concentrated to obtain 31.2 g of product with a yield of 90.7%.

[0069] (2) Preparation of 3-(2,5-difluorophenyl)-2-methyl-3-oxopropionitrile (formula 4)

[0070] Dissolve methyl 2,5-difluorobenzoate (31.2g, 0.18mol), sodium ethoxide (14.7g, 0.22mol) and propionitrile (11.9g, 0.22mol) in 100mL of ethanol, heat the reaction to the end, and The solvent was concentrated to the remaining 20 mL, water was added, and extracted with ethy...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of chemical drug intermediate preparation and relates to a preparation method of an isavuconazole intermediate. The preparation method is a 4-(2-((2R, 3R)-3-(2, 5-difluorophenyl)-3-hydroxy-4-(1H-1, 2, 4-triazole-1-yl)butane-2-yl)thiazole-4-yl)benzontrile preparation method. The 4-(2-((2R, 3R)-3-(2, 5-difluorophenyl)-3-hydroxy-4-(1H-1, 2, 4-triazole-1-yl)butane-2-yl)thiazole-4-yl)benzontrile has a structural formula (I) shown in the description.

Description

1. Technical field [0001] The invention belongs to the technical field of preparation of chemical drug intermediates, in particular to a preparation method of isavuconazole intermediates, namely 4-(2-((2R,3R)-3-(2,5-difluorophenyl )-3-Hydroxy-4-(1H-1,2,4-triazol-1-yl)butane-2-yl)thiazol-4-yl)benzonitrile preparation method. 2. Background technology [0002] The incidence of invasive fungal infections has increased steadily over the past 20 years. With the increase in the number of patients with compromised immune systems such as chemotherapy, transplantation, HIV / AIDS infection, or diabetes, the incidence of fungal infections is increasing, and some fungal infections have a high fatality rate. fungal drugs. Isavuconazole is the latest triazole antifungal drug developed by Roche. Its mechanism of action is to inhibit the key enzyme of ergosterol biosynthesis on the fungal cell membrane - sterol 14a-demethylase, thereby destroying the integrity of the membrane and affecting ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D417/06
Inventor 王爱臣李丽
Owner KBP BIOSCIENCES CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products